abstract |
CRISPR/CAS-related methods, compositions and components for editing a target nucleic acid sequence or modulating expression of a target nucleic acid sequence, and their application related to cancer immunotherapy, including adoptive delivery of engineered T cells or T cell precursors Is provided. |